HEATHER IRVING: Open Payments
NPI 1598199770 · ARKANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 18 payments from 10 companies in 2025. Trend: 2023 $249 · 2024 $119 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $136 |
| Lundbeck LLC | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Bioventus LLC | 1 | $26 |
| Baxter Healthcare | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Edwards Lifesciences Corporation | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, REXULTI, XIFAXAN, JARDIANCE, EXOGEN ULTRASOUND BONE HEALING SYSTEM, Hillrom - Cardiac Ambulatory Monitor, FANAPT.
Industry payments across KS — which companies pay providers there.
